SCHEMBL9821030

SCHEMBL9821030

Cc1nc2ccccc2c(CCN)c1CO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 4/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ NUDT1 P36639 1/20 0.45
▸ GPR3 P46089 1/20 0.44
▸ TP53 P04637 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MPO P05164 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ ERN1 O75460 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970688 0.80 PDE10A (0.56) SMN1; SMN2ALDH1A1HPGDHSD17B10GAA
SCHEMBL5501886 0.78 SMN1; SMN2 (0.70) SMN1; SMN2GAAKDM4EGPR3MAPT
SCHEMBL9821014 0.77 GAA (0.44) SMN1; SMN2ALDH1A1HPGDGAAKDM4E
SCHEMBL12767717 0.77 ERN1 (0.54) TLR8SMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23861660 0.74 TLR8 (0.58) TLR8SMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL10640221 0.74 HSD17B10 (0.44) SMN1; SMN2ALDH1A1HPGDHSD17B10GAA
SCHEMBL9611245 0.73 KDM4E (0.57) SMN1; SMN2ALDH1A1HPGDHSD17B10GAA
SCHEMBL15414896 0.70 KDM4E (0.46) SMN1; SMN2ALDH1A1HPGDGAAKDM4E
Ammonia Solution, Strong SCHEMBL29175740 0.69 GPR3 (0.53) TLR8SMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL32659735 0.68 ALDH1A1 (0.61) TLR8SMN1; SMN2ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0258755-B1 ALPHA-ALKYL-4-AMINO-3-QUINOLINE-METHANOLS AND 1-(4-ARALKYLAMINO-3-QUINOLINYL) ALKANONES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-09-11 — — EP claimed
US-4789678-A Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1988-12-06 — — US claimed
EP-0258755-A1 Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-03-09 — — EP claimed
EP-0258755-B1 ALPHA-ALKYL-4-AMINO-3-QUINOLINE-METHANOLS AND 1-(4-ARALKYLAMINO-3-QUINOLINYL) ALKANONES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-09-11 — — EP disclosed
US-4840972-A Relief from memory dysfunction with α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-06-20 — — US disclosed
US-4789678-A Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1988-12-06 — — US disclosed
EP-0258755-A1 Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-03-09 — — EP disclosed
Send feedback